Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Xeljanz for active psoriatic arthritis

June 29, 2018

Researchers present preclinical data for [11C]NOP-46

June 29, 2018

Kymab to test KY-1044 in combination with atezolizumab in clinical trials

June 29, 2018

Melinta Therapeutics describes leads from the pyrrolocytosine class of antibiotics

June 29, 2018

Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement

June 29, 2018

Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas

June 29, 2018

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

June 29, 2018

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

June 29, 2018

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

June 29, 2018

Inovio reports phase I results for INO-4700 in MERS

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...